Inventor · disambiguated record
Raymond Paul Beckett
Also filed as: BECKETT RAYMOND · BECKETT RAYMOND P · BECKETT RAYMOND PAUL
42 granted patents·2 pending applications·455 citations·filing 1993–2018
98Inventor score
Files withBRITISH BIOTECH PHARM33MARS INC4NOVO PHARMACEUTICALS LTD DE2VERNALIS OXFORD LTD2BRITISCH BIOTECH PHARMACEUTICA1
Top patents by PatentIndex Score
44 records- 0189US9266908B2Inhibitors of arginase and their therapeutic applicationsMARS INC·Filed 2012·Granted Feb 23, 2016·18 cites·22 claims
- 0289US6358987B1Metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 2001·Granted Mar 19, 2002·35 cites·32 claims
- 0381US9994594B2Inhibitors of arginase and their therapeutic applicationsMARS INC·Filed 2014·Granted Jun 12, 2018·4 cites·8 claims
- 0481US6124333AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1999·Granted Sep 26, 2000·23 cites·52 claims
- 0580US10538537B2Inhibitors of arginase and their therapeutic applicationsMARS INC·Filed 2018·Granted Jan 21, 2020·2 cites·4 claims
- 0680US6787522B2Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2002·Granted Sep 7, 2004·11 cites·17 claims
- 0777US6503897B1Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2000·Granted Jan 7, 2003·8 cites·9 claims
- 0875US5747514AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1996·Granted May 5, 1998·35 cites·27 claims
- 0974US7323448B2Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2006·Granted Jan 29, 2008·1 cites·2 claims
- 1072US6545051B1Antibacterial hydroxamic acid derivativesBRITISH BIOTECH PHARM·Filed 2000·Granted Apr 8, 2003·3 cites·14 claims
- 1172US5700838AHydroxamic acid derivatives as metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1993·Granted Dec 23, 1997·21 cites·82 claims
- 1270US6716878B1Antimicrobial agentsVERNALIS OXFORD LTD·Filed 2000·Granted Apr 6, 2004·8 cites·24 claims
- 1369US5962529AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1995·Granted Oct 5, 1999·20 cites·11 claims
- 1469US5840939ADerivatives of succinamide and their use as metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1996·Granted Nov 24, 1998·24 cites·16 claims
- 1568US6423690B1Antibacterial agentsBRITISH BIOTECH PHARM·Filed 1999·Granted Jul 23, 2002·19 cites·36 claims
- 1667US5821262AHydroxamic acid derivatives as inhibitors of cytokine productionBRITISH BIOTECH PHARM·Filed 1994·Granted Oct 13, 1998·19 cites·15 claims
- 1764US7148198B2Antibacterial agentsBRITISH BIOTECH PHARM·Filed 2004·Granted Dec 12, 2006·1 cites·4 claims
- 1864US6271262B1Metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1998·Granted Aug 7, 2001·18 cites·32 claims
- 1964US5859253AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1998·Granted Jan 12, 1999·16 cites·1 claims
- 2064US5763621AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1995·Granted Jun 9, 1998·21 cites·12 claims
- 2162US6022898AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1995·Granted Feb 8, 2000·14 cites·53 claims
- 2261US5861436AHydroxamic acid derivatives as metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1997·Granted Jan 19, 1999·16 cites·7 claims
- 2360US6908911B1Antibacterial agentsBRITISH BIOTECH PHARM·Filed 1999·Granted Jun 21, 2005·8 cites·2 claims
- 2459US6028110ASuccinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitorsBRITISH BIOTECH PHARM·Filed 1995·Granted Feb 22, 2000·16 cites·16 claims
- 2559US5902791AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1995·Granted May 11, 1999·14 cites·20 claims
- 2658US6441042B1Hydroxamic acid derivatives as antibacterialsBRITISH BIOTECH PHARM·Filed 1999·Granted Aug 27, 2002·12 cites·16 claims
- 2755US6124332AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1999·Granted Sep 26, 2000·9 cites·46 claims
- 2855US2017183362A1Inhibitors of arginase and their therapeutic applicationsMARS INC·Filed 2017·Application pending·0 cites
- 2952US6124329AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1999·Granted Sep 26, 2000·7 cites·10 claims
- 3051US6017889AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1998·Granted Jan 25, 2000·8 cites·18 claims
- 3151US5652262AHydroxamic acid derivatives as metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1994·Granted Jul 29, 1997·11 cites·20 claims
- 3249US5643964ANatural amino acid derivatives as metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1993·Granted Jul 1, 1997·5 cites·11 claims
- 3346US5696082AHydroxamic acid derivativesBRITISH BIOTECH PHARM·Filed 1994·Granted Dec 9, 1997·5 cites·7 claims
- 3445US6103739AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1996·Granted Aug 15, 2000·6 cites·10 claims
- 3545US5866717AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1995·Granted Feb 2, 1999·6 cites·13 claims
- 3644US6022873AMetalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1998·Granted Feb 8, 2000·5 cites·22 claims
- 3740US5908851ADerivatives of succinamide and their use as metalloproteinase inhibitorBRITISH BIOTECH PHARM·Filed 1996·Granted Jun 1, 1999·3 cites·17 claims
- 3836US2007129310A1Antibacterial agentsVERNALIS OXFORD LTD·Filed 2002·Application pending·0 cites
- 3934US6310084B1Metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1998·Granted Oct 30, 2001·1 cites·19 claims
- 4032US10214531B2Substituted amino triazoles, and methods using sameINST FOR DRUG DISCOVERY LLC·Filed 2014·Granted Feb 26, 2019·0 cites·10 claims
- 4130US5840974AMetalloproteinase inhibitorsBRITISCH BIOTECH PHARMACEUTICA·Filed 1997·Granted Nov 24, 1998·2 cites·24 claims
- 4228US7241921B2Bacterial enzyme inhibitorsNOVO PHARMACEUTICALS LTD DE·Filed 2002·Granted Jul 10, 2007·0 cites·12 claims
- 4326US7323596B2Antimicrobial agentsNOVO PHARMACEUTICALS LTD DE·Filed 2001·Granted Jan 29, 2008·0 cites·9 claims
- 4419US6476067B1N-formyl hydroxylamine derivatives as antibacterial agentsBRITISH BIOTECH·Filed 1999·Granted Nov 5, 2002·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Raymond Paul Beckett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →